CP
Cefpodoxime
ANTI-INFECTIVE
INDICATION
(1) Lower respiratory tract infections (2) Upper respiratory tract infections (3) Sexually transmitted diseases, (4) Uncomplicated urinary tract infection (5) Skin & soft tissue infections (6) Childhood infections.
DOSAGE AND ADMINISTRATION
CP (Cefpodoxime Proxetil) tablet should be administered orally with food to enhance absorption. CP (Cefpodoxime Proxetil) suspension may be given without regard to food.
The recommended doses, durations of treatment, applicable patient populations are as below :
| Type of Infection | Dose Frequency | Duration |
| Acute community acquired pneumonia | 200 mg 12 hourly | 14 days |
| Acute bacterial exacerbations of chronic bronchitis | 200 mg 12 hourly | 10 days |
| Uncomplicated gonorrhea (men /women) | Single dose 200 mg | |
| Rectal gonococcal infection in women | Single dose 200 mg | |
| Skin & Skin structure infection | 400 mg 12 hourly | 7 – 14 days |
| Pharyngitis and/or tonsillitis | 100 mg 12 hourly | 5 – 10 days |
| Uncomplicated urinary tract infection | 100 mg 12 hourly | 7 days |
| Acute maxillary sinusitis | 200 mg 12 hourly | 10 days |
Child : 15 days – 6 months : 4 mg / kg every 12 hours
6 months – 2 years : 40 mg every 12 hours
3 years – 8 years : 80 mg every 12 hours
Over 9 years : 100 mg every 12 hours
COMPOSITION
Tablet 200 : Cefpodoxime Proxetil USP 200 mg.
Powder for Suspension : Cefpodoxime Proxetil USP 40 mg /5 ml.
DS Powder for Suspension : Cefpodoxime Proxetil USP 80 mg /5 ml.
Paediatric Drops : Cefpodoxime Proxetil USP 20 mg / ml.
